- Home
- AXSM vs STNE Comparison
AXSM vs STNE Comparison
Compare AXSM & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- STNE
- Stock Information
- Founded
- AXSM 2012
- STNE 2012
- Country
- AXSM United States
- STNE Cayman Islands
- Employees
- AXSM N/A
- STNE N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- STNE EDP Services
- Sector
- AXSM Health Care
- STNE Technology
- Exchange
- AXSM Nasdaq
- STNE Nasdaq
- Market Cap
- AXSM 5.1B
- STNE 3.9B
- IPO Year
- AXSM 2015
- STNE 2018
- Fundamental
- Price
- AXSM $105.44
- STNE $16.10
- Analyst Decision
- AXSM Strong Buy
- STNE Buy
- Analyst Count
- AXSM 17
- STNE 8
- Target Price
- AXSM $171.65
- STNE $15.63
- AVG Volume (30 Days)
- AXSM 649.3K
- STNE 6.0M
- Earning Date
- AXSM 08-04-2025
- STNE 08-13-2025
- Dividend Yield
- AXSM N/A
- STNE N/A
- EPS Growth
- AXSM N/A
- STNE N/A
- EPS
- AXSM N/A
- STNE N/A
- Revenue
- AXSM $432,157,000.00
- STNE $2,314,839,446.00
- Revenue This Year
- AXSM $62.84
- STNE $24.21
- Revenue Next Year
- AXSM $60.02
- STNE $7.09
- P/E Ratio
- AXSM N/A
- STNE N/A
- Revenue Growth
- AXSM 72.16
- STNE 12.87
- 52 Week Low
- AXSM $72.21
- STNE $7.72
- 52 Week High
- AXSM $139.13
- STNE $16.32
- Technical
- Relative Strength Index (RSI)
- AXSM 47.99
- STNE 65.61
- Support Level
- AXSM $102.26
- STNE $15.64
- Resistance Level
- AXSM $106.35
- STNE $16.32
- Average True Range (ATR)
- AXSM 3.09
- STNE 0.58
- MACD
- AXSM 0.15
- STNE 0.11
- Stochastic Oscillator
- AXSM 66.44
- STNE 94.83
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About STNE StoneCo Ltd.
StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.